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Abstract The aim of the study was to estimate the
changes caused by oxidative stress in structure and func-
tion of membrane of erythrocytes from patients with met-
abolic syndrome (MS). The study involved 85 patients with
MS before pharmacological treatment and 75 healthy vol-
unteers as a control group. Cholesterol level, lipid peroxi-
dation, glutathione level (GSH), and antioxidant enzyme
activities in erythrocytes were investigated. The damage to
erythrocyte proteins was also indicated by means of
activity of ATPase (total and Na?,K? ATPase) and thiol
group level. The membrane fluidity of erythrocytes was
estimated by the fluorescent method. The cholesterol con-
centration and the level of lipid peroxidation were signifi-
cantly higher, whereas the concentration of proteins thiol
groups decreased in the patient group. ATPase and GSH
peroxidase activities diminished compared to those in the
control group. There were no differences in either catalase
or superoxide dismutase activities. The membrane fluidity
was lower in erythrocytes from patients with MS than in
the ones from control group. These results show changes in
red blood cells of patients with MS as a consequence of a
higher concentration of cholesterol in the membrane and an
increased oxidative stress.
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The metabolic syndrome (MS) was identified as a multi-
plex risk factor for cardiovascular disease which is one of
the major causes of death. Overweight or obesity, abnormal
lipid metabolism, hypertension, and insulin resistance are
the major contributors in MS.
According to the International Diabetes Federation (IDF)
new definition, a diagnosis of MS can be made when a person
has central obesity (waist circumference[94 cm for Europid
men and [80 cm for Europid women) and two out of four
additional factors are present: raised triglyceride level
C150 mg/dL or specific treatment for this lipid abnormality,
reduced HDL cholesterol level \40 mg/dL for men and
\50 mg/dL for women or specific treatment for this lipid
abnormality, raised blood pressure (systolic C130 mm Hg or
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diastolic C85 mm Hg) or treatment of previously diagnosed
hypertension and raised fasting plasma glucose C100 mg/dL
(5.6 mM) or previously diagnosed type 2 diabetes [1].
The MS is an increasingly significant global health
problem. The National Health and Nutrition Examination
Survey 1999–2002 showed that almost 40 % of the U.S.
adults were classified as having the MS [2]. The prevalence
of MS among Polish adults is estimated at the level of
23 % (men) and 20 % (women) [3].
The MS is believed to be a consequence of a sedentary
lifestyle, excessive intake of calories and physical inac-
tivity, although genetic factors are also involved [4, 5].
The elevated oxidative stress, increased leptin and
decreased adiponectin levels, the activation of inflamma-
tory cytokines and prothrombotic mediators are associated
with MS [6, 7]. The reduction of antioxidant enzyme
activities and an increase in lipid peroxidation are results of
a prolonged state of oxidative stress.
The following study aims to investigate the changes in the
plasma membrane of erythrocytes and in the activities of
antioxidant enzymes caused by the MS. Alterations in plasma
lipid profile and oxidative stress can affect erythrocyte




The study involved 75 healthy individuals and 85 patients
with MS diagnosed according to IDF definition. The
exclusion criteria were as follows: (i) secondary dyslipide-
mia, (ii) any acute or chronic inflammatory processes, (iii)
arterial hypertension, (iv) diabetes mellitus, (v) impaired
renal or hepatic function, (vi) treatment with hypolipidemic,
hypotensive, anticoagulant drugs, (vii) antioxidant therapy,
(viii) abuse of alcohol or smoking cigarettes.
These experiments were conducted in accordance with
ethical standards as formulated in Helsinki Declaration of
1975 (revised 1983); consent number 241/06/KB of
Commission of Medical Research Ethics of Medical Uni-
versity of Lodz, Poland.
Blood from MS patients was obtained from the
Department of Clinical Pharmacology, Medical University
of Lodz. The samples from healthy volunteers were pro-
vided by the Central Blood Bank of Lodz. Blood was
collected with anticoagulant (23 mM citric acid, 45.1 mM
trisodium citrate, 45 mM glucose) in 5:1 ratio.
Erythrocytes
Erythrocytes were obtained from blood by centrifugation
(6009g, 10 min, 4 C) and then washed three times with
cold 0.9 % NaCl. They were examined immediately after
isolation.
Red cell membrane preparation
Erythrocyte membranes were prepared by the method of
Dodge [8] with buffer modification. Erythrocytes were
hemolyzed with 20 mM Tris–HCl buffer, pH 7.4, supple-
mented with 1 mM EDTA and 0.01 % PMSF on ice for
15 min. The erythrocyte membranes were centrifuged at
20,0009g for 5 min. The membranes were washed several
times with the above-mentioned buffer until the ‘‘white
ghost’’ (hemoglobin-free) state was attained. All buffers
were cooled to 4 C prior to use and the whole preparation
procedure was conducted on ice.
The protein concentration was estimated according to
the method of Lowry [9]. The concentration of protein in
the sample was read from a calibration curve in the range
50–300 lg proteins/ml using albumin from bovine serum
as the standard.
Cholesterol concentration
The extraction of lipids from erythrocytes was carried out
according to the method of Rodriguez-Vico [10] using
chloroform/methanol mixture (2:1 v/v). The concentration
of cholesterol was determined using Liebermann–Burchard
reagent [11] and was expressed as milligrams of choles-
terol per milliliter of packed cells (mg HC/ml packed cell).
Peroxidation of lipids
The peroxidation of lipids was estimated by the measurement
of compounds reacting with 2-thiobarbituric acid (TBA)
according to the method of Stock and Dormandy [12]. The
absorbance was read at 532 nm. The concentration of TBARS
was calculated using a millimolar absorption coefficient for
malondialdehyde, e = 1.5 9 105 mol-1 dm3 cm-1. The
hemoglobin concentration was determined by Drabkin
method [13]. Absorbance was read at 540 nm. The results
were expressed as lmol TBARS/g Hb.
ATPase activity
The activity of ATPase was measured by means of the
method of Bartosz [14] based on the quantification of
orthophosphate released from ATP during the incubation of
erythrocyte membranes with medium (1 mmol/dm3 ATP,
10 mmol/dm3 MgCl2, 100 mmol/dm
3 buffer Tris–HCl, pH
7.4 for total ATPase activity and additionally supplemented
with 0.1 mmol/dm3 ouabain to verify activity of Na?/K?
ATPase). The concentration of orthophosphate released
from ATP was determined in supernatant by the method of
268 Mol Cell Biochem (2013) 378:267–273
123
van Veldhoven and Mannaerts [15] and was read from a
calibration curve in the range of 2–20 lM using KH2PO4
as the standard. The results were expressed as nmol
orthophosphate/mg proteins 9 h. The activity of Na? K?
ATPase was quantified as a difference between ouabain
treated and non-treated membranes.
Concentration of thiol groups and glutathione level
The level of thiol groups in erythrocyte membranes and of
glutathione (GSH) in erythrocytes was estimated according
to the method of Ellman with 5,50-dithiobis-(2-nitrobenzoic
acid) (DTNB). The concentration of –SH groups was cal-
culated using a milimolar absorption coefficient for 2-nitro-
5-thiobenzoate (NTB-), e412 = 13.6 mmol
-1 dm3 cm-1
[16]. The results were expressed as lmol –SH/mg proteins
or lmol GSH/ml packed cell.
Fluidity of erythrocyte membranes
The fluidity of erythrocyte membranes was measured by
means of fluorescent anisotropy using two fluorescent probes:
1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[40-(trimethy-
lammonium)phenyl]-6-phenyl-1,3,5-hexatriene (TMA–DPH).
DPH is localized in hydrophobic region near the center of the
bilayer, while TMA–DPH is incorporated into the polar region
of the erythrocyte membrane. The increase in fluorescence
anisotropy indicates that the membrane becomes more rigid
(less fluid) [17].
Fluorescence anisotropy measurements were carried out
with an LS-50B fluorescent spectrometer (Perkin–Elmer,
UK). The excitation and emission wavelengths were 348
and 426 nm, respectively. The cuvette holder was tem-
perature controlled (37 C). Erythrocyte membranes were
diluted with buffered saline to protein concentration of
100 lg/ml. Final concentration of fluorescent probes was
1 lmol/l.
The fluorescence anisotropy (r) of the samples was
calculated by the fluorescence data manager program using
the following equation:
r ¼ ðIvv  GIVHÞ= IVV þ 2GIVHð Þ
where IVV and IVH were the vertical and horizontal fluo-
rescence intensities, respectively, to the vertical polariza-
tion of the excitation light beam. The factor G = IHV/IHH
corrects the polarizing effects of the monochromator.
Antioxidant enzymes
Superoxide dismutase (SOD) activity was estimated
according to the method of Misra and Fridovich [18] with
epinephrine. The result was expressed as U/g Hb.
The activity of catalase (CAT) was measured by means
of the method of Aebi [19]. CAT activity was expressed as
U/g Hb.
The glutathione peroxidase (GPx) activity was estimated
according to the method of Rice-Evans et al. [20]. The
result was expressed as U/mg Hb.
Statistical analysis
The results are presented as mean ± SD. Differences
between groups were assessed by an unpaired Student’s
t test. The statistical analysis was performed using
STATISTICA ver 9.0 PL software (StatSoft Inc., Tulsa,
USA).
Results
The study cohort included 85 patients (37 men, 48 women).
The control group included 75 healthy volunteers (33 men,
42 women). Patients with MS had significantly higher
waist circumference, BMI values, levels of total cholesterol
(increase about 21 %), LDL-C (increased by 23 %), tri-
glycerides (increased by 267 %), glucose (increased by
16 %), systolic and diastolic pressure, and significantly
lower level of HDL-C (decreased by 26 %) when com-
pared to healthy controls. Level of CRP did not differ
significantly between groups (Table 1).
Patients with MS had significantly higher levels of
cholesterol (about 45 %) in erythrocyte membrane in







Age 50.3 ± 8.2 55.9 ± 7.4
Men/women 33/42 37/48
Waist circumference (cm) 75.7 ± 10.0 98.1 ± 18.8 0.001
Body weight (kg) 67.0 ± 7.9 90.7 ± 12.5 0.001
BMI (kg/m2) 24.9 ± 2.2 30.5 ± 3.4 0.001
Systolic pressure (mmHg) 117.2 ± 11.7 132.7 ± 7.4 0.001
Diastolic pressure
(mmHg)
71.2 ± 6.9 79.2 ± 6.7 0.001
hs-CRP (mg/l) 1.6 ± 1.4 2.7 ± 2.3 NS
Glucose (mg/dl) 82.3 ± 9.2 95.7 ± 10.5 0.001
Total cholesterol (mg/dl) 199.5 ± 24.5 242.2 ± 36.8 0.001
LDL-C (mg/dl) 120.7 ± 19.8 148.8 ± 35.2 0.01
HDL-C (mg/dl) 58.7 ± 10.8 43.8 ± 9.8 0.001
TG (mg/dl) 96.5 ± 29.4 258.2 ± 94.9 0.001
hs-CRP high sensitivity C-reactive protein, LDL-C low density lipo-
protein cholesterol, HDL-C high density lipoprotein cholesterol, TG
triglycerides, NS non-statistical significant
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comparison to healthy controls (Table 2). The increase in
cholesterol concentration in plasma, especially LDL-C, led
to increase in the accumulation of cholesterol in erythro-
cyte membrane.
In erythrocytes from MS patients, higher level of lipid
peroxidation (about 37 %) in comparison to healthy con-
trols was observed (Table 2). This might be a consequence
of the increase in the level of oxidants caused by redox
imbalance in cells.
Patients with MS demonstrated substantially lower
membrane fluidity (about 10 % higher fluorescent anisot-
ropy values for both probes) than the control group
(Table 2). Membrane fluidity depends on the composition of
lipids and proteins. Higher level of cholesterol decreases
membrane fluidity, especially in polar region of the mono-
layer. Lipid peroxidation also disturbs membrane fluidity.
Incorporation of polar group (ketone, aldehyde, hydroxyl,
superoxide) to double bond in the hydrophobic region leads
to impairment of the structure of membrane and affects other
parameters.
The concentration of thiol groups in erythrocyte mem-
brane observed for patients with MS was significantly
lower (about 16 %) than in the control group (Table 3).
The altered level of thiol groups may be a result of the
modification of protein conformation or directly damage
caused by free radicals. The decrease in total ATPase
activity (8.4 %) and Na? K? ATPase activity (26 %) was
observed in erythrocytes from MS patients in comparison
with the control group (Table 3). Lower activity of ATPase
may be caused by change in membrane viscosity (fluidity)
or by direct protein damage by free radicals or other
products emerging during lipid peroxidation.
The activity of GPx for patients with MS was signifi-
cantly lower (13 %) than that observed in the control
group. No significant changes in activities of SOD or CAT
were observed. The concentration of GSH was significantly
lower (8 %) in patients with MS in comparison to the
control group (Table 4).
Higher level of lipid peroxidation and lower activity of
GPx may suggest that patients with MS demonstrate higher
level of oxidative stress than the control group.
Discussion
The oxidative stress plays an important role in dysfunction of
endothelial pathogenesis, hypertension, inflammation condi-
tions, atherosclerosis [21], hypercholesterolemia [22], and
diabetes [23]. An intensification of oxidative stress in patients
with MS was previously reported [24]. Shim et al. [25]
observed an important growth in the number of neutrophils,
lymphocytes, monocytes, and eosinophils, which generate a
large amount of reactive oxygen species (ROS) after stimu-
lation in patients with MS. As a result of higher generation of
ROS, the damage of lipids, proteins, and nucleic acids is
observed in cells. Mittal and Kant [26] observed an increase
of concentration of malondialdehyde in erythrocytes from
postmenopausal woman suffering from obesity, which
directly correlates with body mass index. An increase in the
concentration of TBARS and conjugated dienes in erythro-
cytes derived from patients diagnosed with type-2 hyper-
cholesterolemia was reported [22]. Plasma membrane lipids
are documented to be the major targets for ROS in erythro-
cytes. In this study, the level of lipid peroxidation (TBARS)
was significantly higher in erythrocytes from patients with
MS in comparison to the control group. This result suggests
disturbance of pro- and antioxidant balance.
The major disturbance in MS is an abnormal lipid
metabolism: elevated plasma triglycerides, increased level
of LDL, and decreased level of HDL. The altered
Table 2 Cholesterol concentration, level of lipid peroxidation and membrane fluidity in erythrocytes for control and MS patients groups
Parameter Control group MS patients p
Total cholesterol content (mg CH/ml packed cell) 2.82 ± 0.64 (n = 56) 4.09 ± 1.19 (n = 80) 0.001
Lipid peroxidation (lmol TBARS/g Hb) 0.329 ± 0.078 (n = 73) 0.453 ± 0.140 (n = 82) 0.001
TMA–DPH fluorescent anisotropy (r) 0.308 ± 0.019 (n = 22) 0.339 ± 0.047 (n = 28) 0.01
DPH fluorescent anisotropy (r) 0.271 ± 0.022 (n = 22) 0.297 ± 0.032 (n = 28) 0.005
Table 3 Thiol groups and ATPase activity in erythrocyte for control and MS patient groups
Parameter Control group MS patients p
Total thiol groups content (nmol –SH/mg proteins) 81 ± 25 (n = 34) 68 ± 20 (n = 78) 0.01
Total ATPase activity (nmol Pi/mg protein 9 h) 536.8 ± 134.5 (n = 52) 491.6 ± 116.8 (n = 70) 0.05
Na?, K? ATPase activity (nmol Pi/mg protein 9 h) 249.5 ± 86.7 (n = 52) 185.0 ± 68.5 (n = 70) 0.001
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membrane microviscosity reflects the changes of mem-
brane lipid composition resulting from intensive exchange
between circulating and membrane lipids, as well as from
abnormal cellular lipid synthesis and metabolism [27]. The
LDL of blood plasma was capable of exchanging the
cholesterol with erythrocyte membranes [28]. The con-
centration of total cholesterol in erythrocytes, derived from
MS patients, was significantly higher when compared to
that of the control group. These results confirm data
obtained for erythrocytes from patients with hypercholes-
terolemia [22, 29]. Hypercholesterolemic people demon-
strate a higher erythrocyte membrane cholesterol/
phospholipid ratio. This alteration of the lipid membrane
correlates inversely with the plasma concentration of HDL-
cholesterol [30]. The higher level of cholesterol, especially
higher level of LDL-C, and raised production of ROS may
lead to intensification of atherosclerosis processes.
Changes in cholesterol content and level of lipid per-
oxidation affect the membrane fluidity. The decrease in
plasma membrane fluidity was observed as a result of the
increase in the concentration of cholesterol in plasma
membrane [31]. A significant drop in membrane fluidity in
erythrocytes from patients with type-2 hyperlipidemia
together with the increase in cholesterol concentration was
previously reported [22]. In this study, the increase in
fluorescent anisotropy for both fluorescent probes indicates
the decrease in fluidity of plasma membrane in hydrophilic
and hydrophobic regions. The decrease in membrane flu-
idity may further lead to the decrease in the ability of
erythrocytes to change shape and finally to disorder of the
blood flow.
The membrane lipid composition and elevated oxidative
stress may contribute to the changes in the activity of the
main membrane enzymes. A higher cholesterol concen-
tration in the membrane was documented to decrease
activities of Ca2? Mg2? ATPase and Na? K? ATPase, and
disturbs ion transport [32, 33]. The activity of Na? K?
ATPase diminished in persons with familial hypercholes-
terolemia [21]. The decrease in Na? K? ATPase activity
can be also associated with diabetes [34]. The reactive
form of oxygen, nitrogen, and chlorine may modify
membrane protein and may inhibit enzymes, including
ATPases [35, 36]. Also products of lipid peroxidation
might contribute to disturbance of ATPase activity. In the
present study, both the total ATPase and Na? K? ATPase
activities decreased in comparison to those in the control
group. The decrease in Na? K? ATPase activity disturbs
not only transport of Na? and K? ions across membrane,
but also can modify resting potential of membrane and
volume of cell. In addition, Na? gradient is also used as a
source of energy by certain carrier processes, e.g., Na?-
glucose symport. The decrease in Na? K? ATPase activity
may therefore lead to the development of cardiovascular
complications.
GSH plays a key role in cellular homeostasis. It is a
major factor in regulation of cell life, proliferation, and
death. GSH was also involved in cell defense against
prooxidants, both directly as low-weight antioxidants and
as a cofactor for GPx. In the present study, the decrease in
GSH concentration was observed. Substantial decrease in
the GSH concentration and the increase in GSSG/GSH
ratio in patients with hypertension, dyslipidemia, MS, and
obesity were reported [37, 38]. Similar changes in plasma
from patients with type 2 diabetes were also noticed [39].
The decrease in concentration of thiol groups in eryth-
rocytes membranes from type-2 hypercholesterolemic
patients was reported earlier [22]. Thiol groups play an
important role in folding and stability of proteins, including
enzymes, and in the modulation of a variety of activities of
the cell membrane, including transport processes across the
membrane. Thiol groups from membrane proteins are lia-
ble to modifications caused by oxidants or alkyl agent.
Changes in level of thiol groups are a result of the oxidative
damage to membrane proteins or changes in structure of
proteins. In this study, patients with MS demonstrated
lowered contents of proteins thiol groups compared to the
healthy group.
The antioxidant enzymes are major parts of cell defense
against ROS. In the present research, the GPx activity was
significantly decreased, while activities of CAT or SOD
were similar to those in the healthy group. Karaouzen et al.
[40] found correlation between activities of antioxidant
enzymes and aging in healthy and obese men. Activities of
SOD, CAT, and GPx were higher in healthy young men
when compared to those in older men. Activities of SOD
and CAT were enhanced in obese young men and reduced
Table 4 Level of GSH and activities of antioxidant enzymes in control and MS patient groups
Parameter Control group MS patients p
GSH concentration lmol GSH/ml packed cell 1.37 ± 0.37 (n = 75) 1.26 ± 0.29 (n = 74) 0.05
Glutathione peroxidase (GPx) activity U/g Hb 20.91 ± 4.65 (n = 65) 18.25 ± 4.72 (n = 82) 0.001
Catalase (CAT) activity U/mg Hb 261.1 ± 64.2 (n = 70) 261.6 ± 60.3 (n = 80) NS
Superoxide dismutase (SOD) activity U/g Hb 2856 ± 644 (n = 73) 2770 ± 621 (n = 82) NS
NS Non-statistical significant
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in older men, and activity of GPx was lower in both groups.
Mansengo et al. [38] documented lower activities of CAT
and GPx in patients with hypercholesterolemia and
hypertension, while activity of SOD was only reduced in
patients with hypertension. Cardona et al. [37] noticed the
increase in CAT activity and the decrease in GPx activity
in patients with hypertriglyceridemia, regardless of MS.
Also Cardona et al. [41] observed the decrease in GPx
activity, but no changes in activities of SOD or CAT in
blood from patients with MS were observed when com-
pared to those in the control group. It seems that activities
of antioxidant enzymes depend on age of subjects, tissue,
associated illness, and dietary habit.
Conclusions
The above-presented results point to some essential chan-
ges in the erythrocyte plasma membranes. The following
changes occur in plasma membrane lipids: the increase in
cholesterol concentration and in levels of lipid peroxidation
as well as the decrease in plasma membrane fluidity.
Collected data also demonstrate changes in functions of
plasma membrane proteins: the decrease in concentration
of thiol groups and the inhibition of ATPase activity.
Antioxidant enzymes represent an important part of the
antioxidant defense system of aerobic cells. The decrease
in antioxidant levels and increase in lipid peroxidation
resulted in oxidative stress in blood of patients with MS.
The MS is not a disease in the strict sense of this word. It
is a metabolic disorder which has multi-factor pathology.
Changes observed in erythrocytes occur as a result of all
disorders connected to abnormal metabolism of lipids,
diabetes and hypertension.
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